Title

Syntheses and biological activities of disaccharide daunorubicins

Authors

Authors

G. S. Zhang; L. Y. Fang; L. Z. Zhu; J. E. Aimiuwu; J. Shen; H. Cheng; M. T. Muller; G. E. Lee; D. X. Sun;P. G. Wang

Comments

Authors: contact us about adding a copy of your work at STARS@ucf.edu

Abbreviated Journal Title

J. Med. Chem.

Keywords

II DNA CLEAVAGE; TOPOISOMERASE-II; ANTITUMOR ANTHRACYCLINES; SEQUENCE; SPECIFICITY; GLYCOSIDIC LINKAGES; SUGAR MOIETY; ANALOG; OLIGOSACCHARIDES; DERIVATIVES; DOXORUBICIN; Chemistry, Medicinal

Abstract

Carbohydrate moiety is found in many anticancer nature products. To explore the carbohydrate moiety of daunorubicin in enhancing anticancer efficacy, several daunorubicin derivatives bearing disaccharide (1-8) have been synthesized. Their cytotoxicities were tested in leukemia K562 and colon cancer SW620 cells. Topoisomerase II (topo II) poisoning was performed with the in vivo complex of topoisomerase bioassay. In both cell lines, compounds with various terminal 2,6-dideoxy sugars (compounds 1, 3, 5, and 8) showed 30- to 60-fold higher anticancer activity than compounds with 2-deoxy- or 6-deoxy sugar (compounds 6 and 7). Compounds with an alpha-linkage between two sugar units (compound 3) showed 35-fold higher anticancer activity than compounds with a beta-linkage (compound 4). In addition, the anticancer activities of these compounds correlated with their ability to target topo II mediated genomic DNA damage in vivo. Compounds 1 and 3 with 2,6-dideoxy sugars produced more covalent topo-DNA complex than compounds with 2-deoxy sugar (6) and 6-deoxy sugar (7). Compounds with an alpha-configuration of terminal 2,6-dideoxy sugar (compounds 1 and 3) showed higher topo II poisoning than their counterparts with the beta-configuration (compounds 2 and 4). These results indicate that sugar moieties in daunorubicin play a significant role in its anticancer activity and topo II inhibition. The second sugar of disaccharide daunorubicin should possess 2,6-dideoxy with alpha-linkage to the first sugar to exhibit better anticancer activity.

Journal Title

Journal of Medicinal Chemistry

Volume

48

Issue/Number

16

Publication Date

1-1-2005

Document Type

Article

Language

English

First Page

5269

Last Page

5278

WOS Identifier

WOS:000231055300022

ISSN

0022-2623

Share

COinS